A BILL 
To provide for the issuance of a Lyme Disease Research 
Semipostal Stamp. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Stamp Out Lyme Dis-
4
ease Act’’. 
5
SEC. 2. FINDINGS AND PURPOSE. 
6
(a) FINDINGS.—Congress finds the following: 
7
(1) According to the Tick-Borne Disease Work-
8
ing Group, an estimated 291,430 to 437,150 new 
9
04:19 Dec 10, 2019
H5299
2 
•HR 5299 IH
cases of Lyme disease were reported in the United 
1
States in 2016. 
2
(2) The Centers for Disease Control and Pre-
3
vention (CDC) reports that Lyme disease is difficult 
4
to diagnose due to its diverse manifestations and a 
5
lack of reliable testing options. 
6
(3) The National Institutes of Health (NIH) 
7
discovered that while Lyme disease symptoms can be 
8
managed with proper care, the disease currently has 
9
no cure. 
10
(4) The Tick-Borne Disease Working Group re-
11
ports that 10 to 20 percent of Lyme disease patients 
12
will suffer from persistent symptoms which can be 
13
chronic and disabling. 
14
(5) According to the Johns Hopkins Bloomberg 
15
School of Public Health, Lyme disease costs the 
16
United 
States 
healthcare 
system 
up 
to 
17
$1,300,000,000 dollars per year. 
18
(b) PURPOSE.—To afford a convenient way for mem-
19
bers of the public to contribute to funding for Lyme dis-
20
ease and related tick-borne illness research within the Na-
21
tional Institute of Allergy and Infectious Diseases, the 
22
United States Postal Service shall issue a semipostal 
23
stamp (hereinafter in this Act referred to as the ‘‘Lyme 
24
04:19 Dec 10, 2019
H5299
3 
•HR 5299 IH
Disease Research Semipostal Stamp’’) in accordance with 
1
this section. 
2
SEC. 3. LYME DISEASE RESEARCH SEMIPOSTAL STAMP. 
3
(a) TERMS AND CONDITIONS.—The issuance and sale 
4
of the Lyme Disease Research Semipostal Stamp shall be 
5
governed by the provisions of section 416 of title 39, 
6
United States Code, and regulations issued under such 
7
section. 
8
(b) DISPOSITION OF PROCEEDS.— 
9
(1) IN GENERAL.—All amounts becoming avail-
10
able from the sale of the Lyme Disease Research 
11
Semipostal Stamp (as determined under section 
12
416(d) of such title 39) shall be transferred to the 
13
National Institute of Allergy and Infectious Dis-
14
eases, for the purpose described in subsection (a), 
15
through payments which shall be made at least twice 
16
a year. 
17
(2) PROCEEDS NOT TO BE OFFSET.—In accord-
18
ance with section 416(d)(4) of such title 39, 
19
amounts becoming available from the sale of the 
20
Lyme Disease Research Semipostal Stamp (as so de-
21
termined) shall not be taken into account in any de-
22
cision relating to the level of appropriations or other 
23
Federal funding to be furnished in any year to the 
24
04:19 Dec 10, 2019
H5299
4 
•HR 5299 IH
National Institute of Allergy and Infectious Dis-
1
eases. 
2
(c) 
DURATION.—The 
Lyme 
Disease 
Research 
3
Semipostal Stamp shall be made available to the public 
4
for a period of at least 6 years, beginning no later than 
5
12 months after the date of the enactment of this Act. 
6
(d) DEFINITION.—For purposes of this Act, the term 
7
‘‘semipostal stamp’’ refers to a stamp described in section 
8
416(a)(1) of title 39, United States Code. 
9
Æ 
04:19 Dec 10, 2019
H5299
